Granite Point Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Granite Point Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-13,200	Closed	-$697K	–	148
2018 Q1	$697K	Sell	13,200 -6,800	-34%	-$397K	0.07%	75
2017 Q4	$1.36M	Sell	20,000 -10,700	-35%	-$748K	0.13%	45
2017 Q3	$2.53M	Sell	30,700 -9,300	-23%	-$737K	0.53%	21
2017 Q2	$3.75M	Buy	+40,000	New	+$2.45M	0.92%	16

Other funds holding CLVS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Granite Point Capital Management's CLVS Position: Q2 2018 in Review

Granite Point Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2018, closing a stake of 13,200 shares — an estimated $697K sold.

Granite Point Capital Management first reported a position in CLVS in Q2 2017 and held it in 4 quarters. The position peaked at $3.75M in Q2 2017. 210 funds tracked by Wall St. Rank hold CLVS as of Q2 2018.

Granite Point Capital Management reported no remaining Clovis Oncology, Inc. position as of Q2 2018 after selling out during the quarter.
Granite Point Capital Management sold 13,200 Clovis Oncology, Inc. shares in Q2 2018, an estimated $697K.
Granite Point Capital Management first reported a position in Clovis Oncology, Inc. in Q2 2017 and held it in 4 quarters.
Granite Point Capital Management's Clovis Oncology, Inc. position peaked at $3.75M in Q2 2017.
210 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2018.

Based on Granite Point Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.